Therapeutic inhibition of proteasomes in systemic lupus erythematosus

Lignende værker

• The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus
  af: Alexander, Tobias, et al.
  Udgivet: (2015)
• Bortezomib Plus Continuous B Cell Depletion Results in Sustained Plasma Cell Depletion and Amelioration of Lupus Nephritis in NZB/W F1 Mice
  af: Khodadadi, Laleh, et al.
  Udgivet: (2015)
• Long-lived plasma cells are early and constantly generated in New Zealand Black/New Zealand White F1 mice and their therapeutic depletion requires a combined targeting of autoreactive plasma cells and their precursors
  af: Taddeo, Adriano, et al.
  Udgivet: (2015)
• New aspects of the etiopathogenesis of systemic lupus erythematosus
  af: Gaipl, US, et al.
  Udgivet: (2003)
• Perturbations of peripheral B lymphocyte homoeostasis in children with systemic lupus erythematosus
  af: Odendahl, M, et al.
  Udgivet: (2003)